• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5071899)   Today's Articles (92)
For: Huang R, Sheng Y, Xu Z, Wei D, Song X, Jiang B, Chen H. Combretastatin A4-derived payloads for antibody-drug conjugates. Eur J Med Chem 2021;216:113355. [PMID: 33721668 DOI: 10.1016/j.ejmech.2021.113355] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Revised: 02/19/2021] [Accepted: 02/26/2021] [Indexed: 12/18/2022]
Number Cited by Other Article(s)
1
Oh Y, An DE, Park J, Koh B, Cho KJ, Jeon H. Synthesis and evaluation of KX-01 analogs with an exploration of linker attachment points for antibody-drug conjugates. Bioorg Med Chem Lett 2025;120:130114. [PMID: 39880175 DOI: 10.1016/j.bmcl.2025.130114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2024] [Revised: 12/26/2024] [Accepted: 01/26/2025] [Indexed: 01/31/2025]
2
Li T, Yu X, Wan X, Liu J, Zheng J, Sun Z, Zhao Y, Chen J, Chen H, Yang Y, Jiang B. Exploiting synthetic lethality in PDAC with antibody drug conjugates and ATR inhibition. Eur J Med Chem 2025;286:117305. [PMID: 39874630 DOI: 10.1016/j.ejmech.2025.117305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2024] [Revised: 01/10/2025] [Accepted: 01/18/2025] [Indexed: 01/30/2025]
3
Zhao YC, Yan LQ, Xu Y. Recent advances of selenized tubulin inhibitors in cancer therapy. Bioorg Med Chem Lett 2025;116:130037. [PMID: 39581555 DOI: 10.1016/j.bmcl.2024.130037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2024] [Revised: 11/17/2024] [Accepted: 11/19/2024] [Indexed: 11/26/2024]
4
Fantacuzzi M, Carradori S, Giampietro L, Maccallini C, De Filippis B, Amoroso R, Ammazzalorso A. A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates. Eur J Med Chem 2025;281:117021. [PMID: 39500065 DOI: 10.1016/j.ejmech.2024.117021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Revised: 10/23/2024] [Accepted: 10/30/2024] [Indexed: 12/02/2024]
5
Mao Y, Wei D, Fu F, Wang H, Sun Z, Huang Z, Wang Y, Zhang G, Zhang X, Jiang B, Chen H. Development of a MMAE-based antibody-drug conjugate targeting B7-H3 for glioblastoma. Eur J Med Chem 2023;257:115489. [PMID: 37235999 DOI: 10.1016/j.ejmech.2023.115489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Revised: 05/11/2023] [Accepted: 05/13/2023] [Indexed: 05/28/2023]
6
Li Y, Gao Y, Pan Z, Jia F, Xu C, Cui X, Wang X, Wu Y. Fabrication of Poly Dopamine@poly (Lactic Acid-Co-Glycolic Acid) Nanohybrids for Cancer Therapy via a Triple Collaboration Strategy. NANOMATERIALS (BASEL, SWITZERLAND) 2023;13:1447. [PMID: 37176991 PMCID: PMC10180254 DOI: 10.3390/nano13091447] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 04/19/2023] [Accepted: 04/21/2023] [Indexed: 05/15/2023]
7
Wei D, Jiang Y, Mao Y, Xu Z, Chen J, Gao X, Li J, Jiang B, Chen H. Phenyldivinylsulfonamides for the construction of antibody-drug conjugates with controlled four payloads. Bioorg Chem 2023;134:106463. [PMID: 36924655 DOI: 10.1016/j.bioorg.2023.106463] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 02/27/2023] [Accepted: 03/07/2023] [Indexed: 03/17/2023]
8
Wei D, Mao Y, Wang H, Qu S, Chen J, Li J, Jiang B, Chen H. A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates. CHINESE CHEM LETT 2022. [DOI: 10.1016/j.cclet.2022.108091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
9
Guo K, Ma X, Li J, Zhang C, Wu L. Recent advances in combretastatin A-4 codrugs for cancer therapy. Eur J Med Chem 2022;241:114660. [PMID: 35964428 DOI: 10.1016/j.ejmech.2022.114660] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 08/01/2022] [Accepted: 08/02/2022] [Indexed: 12/14/2022]
10
Wei D, Mao Y, Xu Z, Chen J, Li J, Jiang B, Chen H. Site-specific construction of triptolide-based antibody-drug conjugates. Bioorg Med Chem 2021;51:116497. [PMID: 34794002 DOI: 10.1016/j.bmc.2021.116497] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 11/02/2021] [Accepted: 11/02/2021] [Indexed: 11/28/2022]
11
Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues. Eur J Med Chem 2021;223:113656. [PMID: 34171660 DOI: 10.1016/j.ejmech.2021.113656] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 06/14/2021] [Accepted: 06/14/2021] [Indexed: 12/19/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA